Monica Niger
@Mom_enji
Followers
477
Following
5K
Media
8
Statuses
600
GI Medical Oncologist @IstTumori, Milan. Science, travel and sports addict.
Milan, Lombardy
Joined February 2014
RT @ArndtVogel: 🔥Jazz Pharmaceuticals Receives European Commission Marketing Authorization for Ziihera®.(zanidatamab) for the Treatment of….
0
21
0
RT @fedenichetti: Finally published: Real-World outcomes of @IstTumori Molecular Tumor Board treatment recommendations @JCOPO_ASCO @Pruner….
ascopubs.org
PURPOSEThe Molecular Tumor Board (MTB) is an important tool for the selection of molecularly targeted agents (MTAs), but its clinical utility is unconfirmed in real-world practice.MATERIALS AND...
0
3
0
RT @ArndtVogel: T-DXd vs RAM + paclitaxel in 2nd line HER2+ EC/GEJC.#ASCO25.🔎DESTINY-Gastric04 phs-III.👉ORR 44 vs 29%.👉mPFS 6.7 vs 5.6 mo,….
0
12
0
RT @ArndtVogel: Neoadjuvant Gem/Cis vs radical liver resection followed by adjuvant therapy in BTC.#ASCO25.🔎 phase III AIO/CALGP/ACO-GAIN-T….
0
33
0
RT @MassimoDiMaio75: Have a look at my review seeking to help clinicians gain familiarity with the correct reading and interpretation of #….
evidence.nejm.org
There is growing attention paid to patient-reported outcomes and health-related quality of life as end points in clinical trials in oncology. Such results should contribute to the definition of tre...
0
13
0
RT @margheambro1: In this review we go through the key aspects that characterize MSI-H/dMMR cancers, in light of recent diagnostic advances….
0
17
0
RT @TumoriJ: @IstTumori authors investigated feasibility and outcomes of a workflow for identification of germline carriers based on tumour….
journals.sagepub.com
Introduction: Tumour BRCA1/2 sequencing has progressively increased along with the expanding indications for poly(ADP-ribose) polymerase inhibitors. In our stud...
0
7
0
RT @jitcancer: Meet the Author: Dr. Margherita Ambrosini (@margheambro1), an oncologist & PhD student from @HopitalPompidou @IstTumori, is….
0
13
0
RT @g_procopio_: Let's start with last session of grandangolo 2024 with a special focus on rare GU tumors @ACCMEDorg @AndreaNecchi @SpiessP….
0
3
0
RT @ChiaraCrem1: A successful trial by @FoundationGono , a brilliant effort of academic research. Congrats @FilippoPietran4 and team!!!.
0
2
0
RT @fedenichetti: Molecular Characterization and Clinical Relevance of MGMT-Silenced #PancreaticCancer @CancerMedicineJ ..
onlinelibrary.wiley.com
O6-methylguanine-DNA methyltransferase (MGMT) silencing is a validated biomarker in glioblastoma but has not been deeply investigated in pancreatic cancer (PAC). We show that MGMT silencing occurs...
0
1
0
RT @FilippoPietran4: The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite Stable Metasta….
0
4
0
RT @Erman_Akkus: 🧮First-line chemotherapies in advanced pancreatic cancer.@TheLancetOncol . ✅Meta-analysis reaffirms NALIRIFOX /FOLFIRINOX….
0
54
0
RT @ffcd_cancerdig: First communication from the European GI network #Engic . Collaboration between @ffcd_cancerdig and #Gono on Engic02-PR….
0
3
0
RT @TheTennisLetter: Jasmine Paolini’s 2024 Grand Slam season has come to an end. 🔹The woman with the most Grand Slam match wins this yea….
0
138
0
RT @sundar__raghav: Building one of the largest datasets of gastric cancer peritoneal metastases in the world, we unravel new biology of or….
0
26
0
RT @LiaCapizzi: I quarti posti finalmente trovano una dignità . Vengono persino invitati al Quirinale, privilegio fino ad ora riservato solo….
0
303
0